Get the Stockscreener App
0.273
0.52%
0.0014
After Hours:
.26
-0.013
-4.76%
Protagenic Therapeutics Inc stock is traded at $0.273, with a volume of 197.85K.
It is up +0.52% in the last 24 hours and down -52.11% over the past month.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
See More
Previous Close:
$0.2716
Open:
$0.27
24h Volume:
197.85K
Relative Volume:
0.50
Market Cap:
$2.09M
Revenue:
-
Net Income/Loss:
$-5.00M
P/E Ratio:
-0.2374
EPS:
-1.15
Net Cash Flow:
$-3.85M
1W Performance:
-26.02%
1M Performance:
-52.11%
6M Performance:
-55.25%
1Y Performance:
-69.83%
1-Day Range:
$0.26
$0.289
1-Week Range:
$0.26
$0.39
52-Week Range:
$0.26
$1.87
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Name
Protagenic Therapeutics Inc
Sector
Industry
Phone
(212) 994-8200
Address
149 FIFTH AVENUE, NEW YORK
Compare PTIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
0.273 | 2.09M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Protagenic Therapeutics Inc Stock (PTIX) Latest News
PTIX’s Market Whiplash: -23.55% YTD Decline, -25.97% Plunge in 30 Days - The InvestChronicle
Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.37, a 11.82 Surge/Decline - The Dwinnex
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic Therapeutics Inc (PTIX) Shares Plummet Below 1-Year High - The News Heater
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Sees Significant Decrease in Short Interest - Defense World
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - ACCESS Newswire
Performance Tech Stock Hits 52-Week Low at $0.44 Amid Market Challenges - Investing.com
Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement - Defense World
Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register
PTIX stock touches 52-week low at $0.45 amid market challenges - Investing.com Nigeria
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Protagenic Therapeutics (NASDAQ:PTIX) Faces Delisting Threat from NasdaqUnited States Securities and Exchange CommissionWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934D - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity deficit - Investing.com
PTIX stock touches 52-week low at $0.48 amid market challenges - Investing.com India
Protagenic Therapeutics Receives Delist Determination Letter from Nasdaq - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
ARMISTICE CAPITAL, LLC Acquires New Stake in Protagenic Therapeu - GuruFocus.com
Protagenic Therapeutics Inc. Warrant (PTIXW) Quarterly 10-Q Report - Quartz
Protagenic Therapeutics Inc. (PTIX) Quarterly 10-Q Report - Quartzy
Protagenic Therapeutics Completes Private Placement, Raises $1.275 Million - Defense World
Protagenic Therapeutics Raises $1.27M in Private Placement with Warrant Offerings | PTIX Stock News - StockTitan
Protagenic Therapeutics Raises $1.275M for Growth Initiatives - TipRanks
Protagenic Therapeutics Secures $1.275M in Private Placement - TipRanks
Protagenic Therapeutics announces $1.275 million stock sale By Investing.com - Investing.com Canada
Protagenic Therapeutics announces $1.275 million stock sale - Investing.com
Protagenic Therapeutics to sell 1.95M shares at 64c in private placement - TipRanks
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
PTIX stock touches 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
PTIX stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Short Interest in Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Expands By 3,669.0% - Defense World
The Williams Companies, Inc. (NYSE:WMB) Shares Acquired by Mill Creek Capital Advisors LLC - Defense World
Stephens’s latest rating for PTLO stock - Knox Daily
Petratherm Ltd Reports Key Shareholder Changes - TipRanks
ProSiebenSat.1 Media (OTCMKTS:PBSFY) Shares Up 8.7% - Defense World
A look into Prothena Corporation plc (PRTA)’s deeper side - SETE News
Views of Wall Street’s Leading Experts on Proto Labs Inc - SETE News
Top Wall Street Forecasters Revamp Progress Software Price Expectations Ahead Of Q3 Earnings - Benzinga
Pacer Advisors Inc. Has $74.14 Million Stake in Playtika Holding Corp. (NASDAQ:PLTK) - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Rhumbline Advisers - Defense World
Protagonist Therapeutics Inc [NASDAQ: PTGX] Sees Increase in Stock Value - Knox Daily
Propel Hits 52-Week High on KOHO Link - Baystreet.ca
BOK Financial upgraded, Prosperity Bancshares downgraded at Truist (NASDAQ:BOKF) - Seeking Alpha
Roth/MKM flags Playtika stock’s profitability risks despite new IP additions - Investing.com Australia
Progyny Stock Faces Its Biggest Drop Ever After Losing a Major Client. Why These Analysts Like the Stock. - Barron's
Playtika (NASDAQ:PLTK) Rating Reiterated by Wedbush - Defense World
Progyny price target lowered to $25 from $37 at Cantor Fitzgerald - TipRanks
Acadian Asset Management LLC Sells 27,140 Shares of Proto Labs, Inc. (NYSE:PRLB) - Defense World
Protagenic Therapeutics Inc Stock (PTIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):